688 related articles for article (PubMed ID: 7380995)
1. Induction of relaxin secretion in nonpregnant women by human chorionic gonadotropin.
Quagliarello J; Goldsmith L; Steinetz B; Lustig DS; Weiss G
J Clin Endocrinol Metab; 1980 Jul; 51(1):74-7. PubMed ID: 7380995
[TBL] [Abstract][Full Text] [Related]
2. Stimulation of primate luteal function by recombinant human chorionic gonadotropin and modulation of steroid, but not relaxin, production by an inhibitor of 3 beta-hydroxysteroid dehydrogenase during simulated early pregnancy.
Duffy DM; Hutchison JS; Stewart DR; Stouffer RL
J Clin Endocrinol Metab; 1996 Jun; 81(6):2307-13. PubMed ID: 8964869
[TBL] [Abstract][Full Text] [Related]
3. Induction of relaxin secretion in rhesus monkeys by human chorionic gonadotropin: dependence on the age of the corpus luteum of the menstrual cycle.
Ottobre JS; Nixon WE; Stouffer RL
Biol Reprod; 1984 Dec; 31(5):1000-6. PubMed ID: 6518224
[TBL] [Abstract][Full Text] [Related]
4. Pregnancy-specific beta 1-glycoprotein and chorionic gonadotropin-like immunoreactivity during the latter half of the cycle in women using intrauterine contraception.
Seppälä M; Rutanen EM; Jalanko H; Lehtovirta P; Stenman UH; Engvall E
J Clin Endocrinol Metab; 1978 Dec; 47(6):1216-9. PubMed ID: 318094
[TBL] [Abstract][Full Text] [Related]
5. Serum levels of relaxin during the menstrual cycle and oral contraceptive use.
Wreje U; Kristiansson P; Aberg H; Byström B; von Schoultz B
Gynecol Obstet Invest; 1995; 39(3):197-200. PubMed ID: 7789917
[TBL] [Abstract][Full Text] [Related]
6. Variable effects of RU 486 on endometrial maintenance in the luteal phase extended by exogenous hCG.
Croxatto HB; Salvatierra AM; Croxatto HD; Spitz IM
Clin Endocrinol (Oxf); 1989 Jul; 31(1):15-23. PubMed ID: 2598478
[TBL] [Abstract][Full Text] [Related]
7. Effects of an antiprogesterone (RU486) on the hypothalamic-hypophyseal-ovarian-endometrial axis during the luteal phase of the menstrual cycle.
Garzo VG; Liu J; Ulmann A; Baulieu E; Yen SS
J Clin Endocrinol Metab; 1988 Mar; 66(3):508-17. PubMed ID: 2832438
[TBL] [Abstract][Full Text] [Related]
8. Persistent versus transient stimulation of the macaque corpus luteum during prolonged exposure to human chorionic gonadotropin: a function of age of the corpus luteum.
Ottobre JS; Stouffer RL
Endocrinology; 1984 Jun; 114(6):2175-82. PubMed ID: 6723578
[TBL] [Abstract][Full Text] [Related]
9. Suppression of luteal function by a luteinizing hormone-releasing hormone antagonist during the early luteal phase in the stumptailed macaque monkey and the effects of subsequent administration of human chorionic gonadotropin.
Fraser HM; Nestor JJ; Vickery BH
Endocrinology; 1987 Aug; 121(2):612-8. PubMed ID: 3109885
[TBL] [Abstract][Full Text] [Related]
10. Steroidogenic responsiveness of the monkey corpus luteum to exogenous chorionic gonadotropin.
Wilks JW; Noble AS
Endocrinology; 1983 Apr; 112(4):1256-66. PubMed ID: 6832045
[TBL] [Abstract][Full Text] [Related]
11. Late luteal phase administration of RU486 for three successive cycles does not disrupt bleeding patterns or ovulation.
Croxatto HB; Salvatierra AM; Romero C; Spitz IM
J Clin Endocrinol Metab; 1987 Dec; 65(6):1272-7. PubMed ID: 3119656
[TBL] [Abstract][Full Text] [Related]
12. The secretion of human chorionic gonadotropin-like substance in women employing contraceptive measures.
Huang SC; Chen HC; Chen RJ; Hsieh CY; Wei PY; Ouyang PC
J Clin Endocrinol Metab; 1984 Apr; 58(4):646-53. PubMed ID: 6699130
[TBL] [Abstract][Full Text] [Related]
13. [Plasma concentrations of LH and of sex steroids during the normal menstrual cycle and during contraceptive treatment].
Bayard F; Louvet JP; Moatti JP; Smilovici W; Duguet L; Boulard C
J Gynecol Obstet Biol Reprod (Paris); 1975; 4(7):915-26. PubMed ID: 767402
[TBL] [Abstract][Full Text] [Related]
14. Gonadotropin-sensitive progesterone production by rhesus monkey luteal cells in vitro: a function of age of the corpus luteum during the menstrual cycle.
Stouffer RL; Nixon WE; Gulyas BJ; Hodgen GD
Endocrinology; 1977 Feb; 100(2):506-12. PubMed ID: 401732
[TBL] [Abstract][Full Text] [Related]
15. Effect of prostaglandin F2alpha on the luteal phase of the cycle in nonpregnant women.
Arrata WS; Chatterton RT
Am J Obstet Gynecol; 1974 Dec; 120(7):954-9. PubMed ID: 4429112
[TBL] [Abstract][Full Text] [Related]
16. Suppression of corpus luteum function by the gonadotropin-releasing hormone antagonist Nal-Glu: effect of the dose and timing of human chorionic gonadotropin administration.
Dubourdieu S; Charbonnel B; Massai MR; Marraoui J; Spitz I; Bouchard P
Fertil Steril; 1991 Sep; 56(3):440-5. PubMed ID: 1894021
[TBL] [Abstract][Full Text] [Related]
17. The importance of luteinizing hormone in the control of inhibin and progesterone secretion by the human corpus luteum.
McLachlan RI; Cohen NL; Vale WW; Rivier JE; Burger HG; Bremner WJ; Soules MR
J Clin Endocrinol Metab; 1989 Jun; 68(6):1078-85. PubMed ID: 2498381
[TBL] [Abstract][Full Text] [Related]
18. Serum follicle-stimulating and luteinizing hormone and progesterone in single and multiple gestations following induction of ovulation.
Fogel M; Rubin BL; Ossowski R
Am J Obstet Gynecol; 1972 Mar; 112(5):629-39. PubMed ID: 5059593
[TBL] [Abstract][Full Text] [Related]
19. Dissociation of relaxin and progesterone secretion from the primate corpus luteum by acute administration of a 3 beta-hydroxysteroid dehydrogenase inhibitor during the menstrual cycle.
Duffy DM; Stouffer RL; Stewart DR
Biol Reprod; 1995 Aug; 53(2):447-53. PubMed ID: 7492699
[TBL] [Abstract][Full Text] [Related]
20. Intranasal LHRH agonist (Buserelin) after ovulation: a post-coital contraceptive approach.
Lemay A; Faure N; Labrie F; Fazekas AT
Contracept Deliv Syst; 1983 Apr; 4(2):107-25. PubMed ID: 12338631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
